Ali Khawaja, MD
Physical Medicine & Rehabilitation · Hagerstown, MDNPI 1689899361
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,385 of the $2,928 with a category attached, or 81.5%. 27 manufacturers reported payments, led by Abbott at 26.6% of the total. Reporting peaked in 2019 at $1,124 and has fallen 96.5% since, to $40 in 2025.
Across 130 payments — averaging $22.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$780
- Pacira Pharmaceuticals Incorporated$631
- Medtronic$401
- Biodelivery Sciences International, Inc.$209
- Boston Scientific$187
- Amgen$104
- plus $617 from 21 others
What the payments were for
- Speaking & faculty fees$140%
- Travel & lodging$52918%
- Food & beverage$2,38581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 54 | $780 |
| Pacira Pharmaceuticals Incorporated | 6 | $631 |
| Medtronic(3 entities) | 11 | $401 |
| Biodelivery Sciences International, Inc. | 15 | $209 |
| Boston Scientific | 9 | $187 |
| Amgen | 1 | $104 |
| Tersera Therapeutics LLC | 4 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $73 |
| Scilex Pharmaceuticals Inc. | 4 | $61 |
| Lilly USA, LLC | 4 | $49 |
| Saluda Medical Americas, Inc. | 1 | $39 |
| Kaleo, Inc. | 2 | $35 |
| Nevro Corp. | 2 | $30 |
| Si-bone, Inc. | 1 | $30 |
| Stimwave Technologies Incorporated | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| AstraZeneca | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| UCB, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi | 1 | $15 |
| Acorda Therapeutics, Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| Shionogi Inc | 1 | $13 |
| CSL Behring | 1 | $13 |
| Akcea Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$529
- CoreValve Evolut$125
How this compares
$2,928 in reported general payments places this provider in the 85th percentile of 202 physical medicine & rehabilitation providers in Maryland.
See all physical medicine & rehabilitation providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other physical medicine & rehabilitation in Hagerstown
- Cheryl MejiaHagerstown$20K
- Christopher ClarkHagerstown$6K
- David ReeceBethesda$719K
- Gurtej SinghCatonsville$205K
- Akhil ChhatreBaltimore$169K
- Justin WassermanBethesda$51K
- Vivek SindhiGlen Burnie$33K
- Inai MkandawireOwings Mills$23K
- Ronald ShinBaltimore$19K
- Mustafa BroachwalaBaltimore$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.